ARS Pharmaceuticals (SPRY) 2025 Conference June 04, 2025 05:30 PM ET Speaker0 Thank you very much. So I'll present the beginning and I'll invite Eric Carras, our Chief Commercial Officer, up for the commercial part of the presentation so he can present that part. So very happy to be here and present. Next slide. Oh, I'm clicking or they didn't give me that. Okay. There we go. So forward looking statement. So this year has been a very active year for us. This is our first full year of launch of Nefi, which i ...

纪要涉及的公司和行业 - 公司：Bruker（BRKR） - 行业：质谱仪、多组学、半导体、国防与国土安全检测、细胞分析、空间生物学 纪要提到的核心观点和论据 产品创新 - **TIMS Ultra and AIP**：用于传统自下而上蛋白质组学，提升MSMS灵敏度和带宽，与Evocep Ino配合实现每天500个样本的高通量，在单细胞蛋白质组学、亚细胞蛋白质组学和免疫肽组学等领域表现出色，该业务规模约2亿美元，与Team Red竞争[5][6][10] - **TIMS Metabo**：针对小分子高分辨率精确质量市场，包括PFAS研究、代谢组学和脂质组学等应用，灵敏度是现有产品的10倍，能解决注释置信度这一关键痛点，有望在几年内使市场机会翻倍[11][13][15] - **TIMS Omni**：开创了蛋白质组学2.0时代，可进行自上而下的蛋白质组学研究，适用于生物制药决策，目前市场竞争小，预计初期约三分之一的系统将用于生物制药[17][18][25] 市场策略与资源分配 - 因学术市场受政府预算影响，公司将资源重新分配至受政府预算影响较小的市场，如代谢组学、脂质组学、生物制药和应用市场等[22][24] - 为应对不确定性，公司准备在2026年实现适度增长，目标是有机增长6% - 8%，并通过削减成本实现显著的利润率扩张和每股收益增长[32][33] 市场优势与增长机会 - **国防与国土安全检测业务**：规模为3000 - 4000万美元，增长显著，预计明年增长2000万美元，主要得益于欧洲国防投资增加和机场安检需求增长，可带来约50个基点的增长[38][39][42] - **半导体计量业务**：占公司收入的8%，有望增长至10% - 12%，受益于高性能计算、人工智能和芯片制造的发展，公司在该领域技术领先，客户包括台积电和三星等[42][43][45] - **中国市场**：有望从刺激政策中受益，公司的高端研究工具如质谱仪、核磁共振仪和显微镜等需求大，但预算释放时间不确定，若在今年下半年释放，将为2026年带来显著顺风[47][49][51] 新产品与市场拓展 - **Beacon Discovery**：下一代台式细胞分析产品，价格降至50万美元，可拓宽市场，用于抗体发现和细胞系选择等[54][55] - **空间生物学产品**：通过NanoString交易进入该领域，对产品进行创新和改进，解决了IP诉讼问题，提升了性能和通量，与竞争对手相比具有优势，还推出了Painscapes仪器，用于研究细胞核内的位置、相互作用和结构[60][61][65] 其他重要但是可能被忽略的内容 - 学术市场的售后耗材和服务合同比例低于平均水平，且受政府预算影响较大，公司预计2026年学术市场收入下降20% - 25%[22][24] - 公司成功完成了ERP向S4HANA的过渡，有助于提高运营效率[34] - 公司在空间生物学领域的产品通过NanoString销售渠道进行销售，与Akoya和Lunafore等竞争[64]

Achieve Life Sciences (ACHV) 2025 Conference June 04, 2025 05:30 PM ET Speaker0 Good evening, everyone, and welcome to the Jefferies Global Healthcare Conference. My name is Arjun with the Jefferies Investment Banking Team, and it is my great pleasure to introduce Richard Stewart, CEO of Achieve Life Sciences. Speaker1 Thank you very much and thank you for staying late today. It's my great pleasure to introduce you to Achieve Life Sciences and we're at a pivotal point in our development. We have several cat ...

Hologic (HOLX) FY Conference June 04, 2025 05:00 PM ET Speaker0 Thanks for joining us here as we begin to wrap up the second day of the William Blair Growth Stock Conference. If you haven't met me, I'm Andrew Brackman. I'm the diagnostics analyst here at William Blair that covers Hologic. Today, we're pleased to have the team, including CFO, Carleen Oberton and from Investor Relations, Peter Sattler. I am required to tell you that for a full list of research disclosures, please visit williamblair.com, and t ...

Lumentum (LITE) 2025 Conference June 04, 2025 05:00 PM ET Speaker0 To have the team from Lumentum join us, Michael Hultzton, CEO. And I'll go through same fireside format, my questions, but please feel free to raise your hand if you would like to bring up anything. Michael, warm welcome, really appreciate you joining us. And thank you for the positive pre announcement yesterday. Speaker1 Thank you. Speaker0 Yeah, always good to get something exciting before our fireside. Speaker1 We just wanted to keep your ...

Cognizant Technology Solutions (CTSH) 2025 Conference June 04, 2025 05:00 PM ET Speaker0 All right. I think we're going go ahead and get started. Apologies. We're running a few minutes behind here. I'm Jason Kupferberg, the payments processors and IT services analyst here at Bank of America. And we're really excited to have Sharia back with us at the conference again. Thank you very much for your reappearance here. Thank you, Jason. Thank you having Great to see you. Yeah, no, absolutely. And it's good timi ...

BILL Holdings (BILL) 2025 Conference June 04, 2025 05:00 PM ET Speaker0 We are very fortunate to have John Redding here today. John is the newly appointed COO, former CFO. I assume you're still CFO But thanks, John. It's been great. I think we've had Bill at the conference ever since the IPO. Appreciate the support and look forward to the conversation. Thank you, Brad. Speaker1 Absolutely. Good to be here. Speaker0 So maybe we could just start with the news this week on the appointment of the new CFO and yo ...

The Vita Coco Company (COCO) FY Conference June 04, 2025 05:00 PM ET Speaker0 Alright, everybody. We're gonna get started here. Thanks for joining us. I'm John Anderson, the research analyst at William Blair that covers consumer staples and, in this case, Vita Coco. We're happy to have the team from Vita Coco here with us. We have chief executive officer Martin Roper, chief sales officer Charles Veness, and chief financial officer Corey Baker. Vita Coco pioneered packaged coconut water in The US, and it's t ...

908 Devices (MASS) FY Conference June 04, 2025 05:00 PM ET Speaker0 For the nine zero eight devices management presentation. My name is Matt Larue. I cover, tools, including nine zero eight here at Blair. Two quick announcements, before we get to the presentation. Breakout session is in Burnham B on the Second Floor. And then for complete business disclosures, please, visit WilliamBlair.com. Very pleased to have, one of the cofounder and CEO, doctor Kevin Knopf here, as well as CFO, Joe Griffith, who've joi ...

Montrose Environmental Group (MEG) FY Conference June 04, 2025 05:00 PM ET Speaker0 Alright. I think we're gonna get it kicked off here. It's 04:00. Good afternoon, everyone, and welcome. My name is Tim Mulrooney. I'm the research analyst here that covers Montrose. I'm required to inform you that for a complete list of research disclosures or potential conflicts of interest, please visit our website at WilliamBlair.com. So Montrose is a provider of integrated environmental solutions across three segments, c ...